Spectral Ai Inc (MDAI)
$1.6
Insights on Spectral Ai Inc
Increasing Revenue
Revenue is up for the last 3 quarters, 3.44M → 6.32M (in $), with an average increase of 25.7% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -10.62M → -3.20M (in $), with an average increase of 105.2% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 45.7% return, outperforming this stock by 130.3%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 79.6% return, outperforming this stock by 163.0%
Performance
- $1.57$1.65$1.60
1.88%
Downside
Day's Volatility :4.84%
Upside
3.02%
- $1.54$19.50$1.60
3.75%
Downside
52 Weeks Volatility :92.1%
Upside
91.79%
Returns
| Period | Spectral Ai Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -20.79% | 0.0% |
6 Months | -46.67% | 0.0% |
1 Year | -84.64% | 0.0% |
3 Years | -83.4% | -22.6% |
Highlights
Market Capitalization | 44.2M |
Book Value | $0.09 |
Earnings Per Share (EPS) | -1.21 |
Profit Margin | -100.97% |
Operating Margin TTM | -121.11% |
Return On Assets TTM | -47.61% |
Return On Equity TTM | -283.19% |
Revenue TTM | 18.9M |
Revenue Per Share TTM | 0.14 |
Quarterly Revenue Growth YOY | -51.1% |
Gross Profit TTM | 10.8M |
EBITDA | -11.8M |
Diluted Eps TTM | -1.21 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Technicals Summary
Sell
Neutral
Buy
Spectral Ai Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Spectral Ai Inc | -6.98% | -46.67% | -84.64% | -83.4% | -83.51% |
 Stryker Corporation | 4.27% | 16.65% | 22.1% | 34.77% | 82.03% |
 Boston Scientific Corp. | 4.07% | 37.85% | 46.89% | 79.63% | 93.34% |
 Edwards Lifesciences Corp. | 3.26% | 27.0% | 2.23% | -8.36% | 51.45% |
 Abbott Laboratories | -2.62% | -2.21% | -0.86% | -5.87% | 32.8% |
 Medtronic Plc | 0.44% | 2.96% | -1.92% | -33.69% | -13.02% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Spectral Ai Inc | NA | NA | NA | 0.0 | -2.83 | -0.48 | NA | 0.09 |
Stryker Corporation | 38.89 | 38.89 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.5 | 63.5 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 37.45 | 37.45 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 31.83 | 31.83 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 29.48 | 29.48 | 1.52 | 5.2 | 0.07 | 0.04 | 0.03 | 38.29 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Spectral Ai Inc | Buy | $44.2M | -83.51% | NA | -100.97% |
Stryker Corporation | Buy | $129.9B | 82.03% | 38.89 | 16.03% |
Boston Scientific Corp. | Buy | $111.1B | 93.34% | 63.5 | 12.05% |
Edwards Lifesciences Corp. | Buy | $52.4B | 51.45% | 37.45 | 23.01% |
Abbott Laboratories | Buy | $177.8B | 32.8% | 31.83 | 13.96% |
Medtronic Plc | Buy | $106.7B | -13.02% | 29.48 | 11.36% |
Company Information
Organization | Spectral Ai Inc |
Employees | 78 |
CEO | Mr. Wensheng Fan |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$1.60
-3.61%
Keyarch Acquisition Corp
$1.60
-3.61%
Connexa Sports Technologies Inc
$1.60
-3.61%
Us Value Etf
$1.60
-3.61%
First Wave Biopharma Inc
$1.60
-3.61%
Global X Msci Next Emerging
$1.60
-3.61%
Fat Projects Acquisition Corp
$1.60
-3.61%
Capital Link Global Fintech
$1.60
-3.61%
Applied Uv Inc
$1.60
-3.61%